| 1 |
A systematic review and clinical atlas on mucocutaneous presentations of the current monkeypox outbreak: With a comprehensive approach to all dermatologic and nondermatologic aspects of the new and previous monkeypox outbreaks |
|
|
| Homa Pourriyahi, Zeinab Aryanian, Zeinab Mohseni Afshar, Azadeh Goodarzi |
|
| Journal of Medical Virology. 2023; 95(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: A case report and a review of the literature |
|
|
| Yasamin Kalantari, Afsaneh Sadeghzadeh-Bazargan, Zeinab Aryanian, Parvaneh Hatami, Azadeh Goodarzi |
|
| Clinical Case Reports. 2022; 10(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
COVID-19 and COVID-19 vaccine-related dermatological reactions: An interesting case series with a narrative review of the potential critical and non-critical mucocutaneous adverse effects related to virus, therapy, and the vaccination |
|
|
| Arash Pour Mohammad, Farzaneh Mashayekhi, Farnoosh Seirafianpour, Milad Gholizadeh Mesgarha, Azadeh Goodarzi |
|
| Clinical Case Reports. 2022; 10(4) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx |
|
|
| Heidi N. Preez, Colleen Aldous, Melvin R. Hayden, Hendrik G. Kruger, Johnson Lin |
|
| The FASEB Journal. 2022; 36(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders |
|
|
| Farnoosh Seirafianpour, Homa Pourriyahi, Milad Gholizadeh Mesgarha, Arash Pour Mohammad, Zoha Shaka, Azadeh Goodarzi |
|
| Dermatologic Therapy. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Efficacy, safety, tolerability, and satisfaction of N-acetylcysteine and pentoxifylline in lichen planopilaris patients under treatment with topical clobetasol: A triple arm blinded randomized controlled trial |
|
|
| Hossein Ahmadi Kahjoogh, Nafise Yazdanian, Elham Behrangi, Masoumeh Roohaninasab, Pardis Hejazi, Azadeh Goodarzi |
|
| Dermatologic Therapy. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
A systematic review on
COVID
-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles
|
|
|
| Yasamin Kalantari, Zeinab Aryanian, Seyed-Mohamad-Sadegh Mirahmadi, Sanam Alilou, Parvaneh Hatami, Azadeh Goodarzi |
|
| Journal of Cosmetic Dermatology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19 |
|
|
| Heidi N du Preez, Colleen Aldous, Hendrik G Kruger, Lin Johnson, Benedetto Natalini |
|
| Advances in Pharmacological and Pharmaceutical Sciences. 2022; 2022: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease |
|
|
| Carlos A. Labarrere, Ghassan S. Kassab |
|
| Frontiers in Microbiology. 2022; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
A systematic review of N-acetylcysteine for treatment of acne vulgaris and acne-related associations and consequences: Focus on clinical studies |
|
|
| Nafiseh Mardani,Samaneh Mozafarpoor,Azadeh Goodarzi,Farahnaz Nikkhah |
|
| Dermatologic Therapy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2 |
|
|
| Zahra Lotfi, Anousheh Haghighi, Amirhossein Akbarzadehpasha, Samaneh Mozafarpoor, Azadeh Goodarzi |
|
| Frontiers in Medicine. 2021; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations |
|
|
| Niloufar Najar Nobari,Farnoosh Seirafianpour,Milad Dodangeh,Afsaneh Sadeghzadeh-Bazargan,Elham Behrangi,Samaneh Mozafarpoor,Azadeh Goodarzi |
|
| Experimental Dermatology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review |
|
|
| Farzaneh Mashayekhi,Farnoosh Seirafianpour,Arash Pour Mohammad,Azadeh Goodarzi |
|
| International Journal of Clinical Practice. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal |
|
|
| Sergio Pandolfi, Salvatore Chirumbolo, Giovanni Ricevuti, Luigi Valdenassi, Geir Bjørklund, Roman Lysiuk, Monica Daniela Dosa, Larysa Lenchyk, Serafino Fazio |
|
| Basic & Clinical Pharmacology & Toxicology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Skin manifestations as potential symptoms of diffuse vascular injury in critical
COVID
-19 patients |
|
|
| Afsaneh Sadeghzadeh-Bazargan,Mahdi Rezai,Niloufar Najar Nobari,Samaneh Mozafarpoor,Azadeh Goodarzi |
|
| Journal of Cutaneous Pathology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns |
|
|
| Soheil Tavakolpour,Zeinab Aryanian,Farnoosh Seirafianpour,Milad Dodangeh,Ifa Etesami,Maryam Daneshpazhooh,Kamran Balighi,Hamidreza Mahmoudi,Azadeh Goodarzi |
|
| Immunopharmacology and Immunotoxicology. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
A systematic review on treatment-related mucocutaneous reactions in
COVID
-19 patients |
|
|
| Niloufar Najar Nobari,Farnoosh Seirafianpour,Farzaneh Mashayekhi,Azadeh Goodarzi |
|
| Dermatologic Therapy. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
